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Abstract
Background: From 1963–1995, a factory in Willits, Mendocino County, CA used toxic hexavalent chromium (Cr(VI))
without adequate measures to protect the population. We use longitudinal hospital data to compare reproductive
outcomes for two generations in Willits and two generations in the Rest of County (ROC). This is the first study to
quantify the reproductive impact of Cr(VI) in a non-occupational population.
Methods: We searched California hospital discharge data (1983–2014) to find Mendocino County residents born
1950 or later. ZIP-code 95490 identifies Willits residents, with all others living in ROC. We used the Multi-Level
Clinical Classification Software (CCS) to classify health outcomes.
First, we calculated the crude birth rate using an external census denominator. The next two models used self-contained
denominators to assess health of infants and two generations of pregnant women. Finally, we focused on non-pregnant
females and, for comparison, males. Here we added admissions for people who moved, linked and summarized
admissions to the person level, and calculated rates per census population.
Results: We found 29311 newborn records in ROC and 5036 from Willits. At start of period, Willits birth rate was
low and did not recover until 12 years after Plant closure. While the Plant was open, respiratory conditions, perinatal
jaundice, and birth defect rates were higher for Willits infants compared to ROC, but improved post-closure. Risk for
abnormal birthweight and term was high and remained high over the study period.
During the period under study, we identified 31444 admissions of pregnant ROC women and 5558 from Willits. Willits
women had significantly higher risk of pregnancy loss compared to ROC, whether stratified by generation, age group,
or pre- and post-closure. Regardless of when exposed, Willits women continued to have significantly higher rates of
in-hospital terminations, as animal studies of Cr(VI) exposure predict. In life course models, non-pregnant Willits women
have significantly higher risk of reproductive organ conditions and neoplasms compared to ROC.
Conclusions: Adverse reproductive outcomes are elevated and consistent with animal studies. General health
outcomes reflect the same broad effect reported for occupationally exposed workers. For the first time, the detrimental
reproductive effects of non-occupational Cr(VI) exposure in human females and their infants is reported.
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The City of Willits, “Gateway to the Redwoods”, is in
Mendocino County (the County), California. In 1950, a
small auto shop expanded to a machine shop (the Plant)
[1]. By 1959, the Plant manufactured heavy-duty steel
cylinders [2] and, by the early 1960s, militarily-classified
intercontinental ballistic missile cylinders [3, 4].
Steel was hardened with hexavalent chromium mist
(Cr(VI)) which floated through vents in the Plant, polluting
the air in Willits. At the top of the Eel River watershed, the
Plant dumped toxic waste into local creeks and contami-
nated ground water at four sites in and near Willits [5].
After years of turmoil and investigations [6–11], the Plant
declared bankruptcy, closing in late 1995 [12]. Years later,
Agency for Toxic Substances and Disease Registry
(ATSDR) investigators began to report increased risk of ad-
verse health outcomes among Willits residents exposed to
Cr(VI) emissions and ordered remediation to protect pub-
lic health [13–18]. Remediation continues twenty years
after closure [5].
In reports for ATSDR, Underwood and colleagues
[14, 17] highlighted that few health studies address
non-occupational exposure to environmental toxins,
and that little is known about the long-term effect for
men and women exposed during childhood or the re-
productive period. Consistent with the Environmental
Protection Agency (EPA) [19], they recognized that in-
fants and children may be more sensitive to environ-
mental exposures than adults, characterized risks to
children in the Willits area, and felt information was
needed on people who were children at the time of ex-
posure. As a last point, they noted that research on the
effect of Cr(VI) on children was an area with virtually
no scientific information [17]. However, as exposure
began so many years earlier, Harrison thought that too
much time had elapsed to study outcomes [20].
These reports motivated Remy and Clay to use longi-
tudinal hospital data to begin to assess health status for
Willits [21]. After evaluating 1970 to 2000 census data,
they concluded that Willits and the rest of the County
(ROC) were among the more residentially stable areas in
California and were demographically similar. Using
hospital discharge abstracts over the period 1991-2012,
census-based population denominators, and a cross-
sequential (life course) design [22], they found that
Willits residents had a significant increase in illness
compared with ROC.
This paper continues the investigation, now focused on
women born between 1950 and 1989, reproductive age
(15 to 44) when first hospitalized for any reason between
1983 and 2014, and infants born over the same period.
Primary data is hospital discharge abstracts, examining
outcomes for infants, pregnant and non-pregnant women
and, for comparison, men. Availability of this data
allowed us to investigate the reproductive health of two
generations of mothers and infants born to them. The
generational focus allowed us to examine reproductive
consequences for mothers exposed to Cr(VI) at different
life stages and their babies. Most people in Willits were
born and/or grew up when the air was contaminated.
However, most of the older generation (born 1950–1969)
were not exposed until puberty and conceived when the
Plant was open (1983–1996), while most of the younger
generation (born 1970–1989) were exposed in utero, dur-
ing childhood, and conceived after closure (1997–2014).
Hexavalent chromium (Cr(VI))
Although the Plant exposed Willits to various chemicals,
we focus on Cr(VI) as the exposure of most concern for
adverse outcomes. Cr(VI) attracted the primary interest of
regulatory agencies that concluded past exposures affected
community health [14]. This toxic makes its way into the
domestic environment when facilities emit contaminated
air, which then enters nearby water and soil. Principal
non-occupational exposures occur by breathing contami-
nated air or drinking contaminated water.
A large body of research established serious reproductive
toxicity in female and male animals and occupationally
exposed men [23]. A major report summarized five
studies of female animals exposed to Cr(VI) during
gestation, and four of female animals exposed before
reproductive age, with a focus on the resultant litters
[24]. The first five studies had similar findings: in-
creased pre- and post-implantation loss, resorption fre-
quency, more dead and fewer fetuses per litter, low fetal
weight, renal pelvis dilation, and bone or skeletal de-
fects. In the second group of studies, exposure occurred
long before mating. Results on litters were strikingly simi-
lar to litters of females exposed during gestation: de-
creased implantation, decrease in live fetuses, increased
resorption frequency, and bone or skeletal defects. Others
added more information on defects [25, 26] and repro-
ductive organ damage [27–29].
Authors of one report [30] in the review felt that de-
creased numbers of implantation sites and viable fetuses,
and increased resorption suggested disturbance of re-
productive endocrine functions with multiple sites of
toxicity along the hypothalamic-pituitary-ovarian uterine
axis. They also suggested increased resorption was due to
modification of the uterine lining before arrival of the
embryo.
The number of corpora lutea also decreased [31–34].
Premature ovarian failure (POF) was noted when litters
of exposed mothers reached reproductive age. Exposure
during prenatal development causes POF in progeny by
altering the expression pattern of certain enzymes in
fetal ovaries [33, 35].
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Whether exposed before or during gestation, most
studies found an increase in chromium levels in the pla-
centa, suggesting Cr(VI) accumulates in maternal tissues
during treatment, remains during the untreated mating
period, and crosses the placenta into fetuses during ges-
tation [24]. In exposed male experimental animals and
male humans, sperm viability, motility, and morphology is
abnormal, and male workers report frequent spontaneous
abortions in spouses [24, 36].
Only five studies describe adverse reproductive effects
in occupationally exposed women. Similar to animal
studies, these found: increased spontaneous abortions
[37]; decreased intrauterine growth of fetuses resulting
in low birth weight [38, 39]; high levels of Cr(VI) in the
blood, urine, and umbilical cord blood [38, 40]; and in
neonates, Cr(VI) in the cord blood and cord lymphocyte
mutations [32, 41].
Here, we examine if similar outcomes occurred in a do-
mestically exposed population of infants and pregnant
women over the 32-year period 1983–2014, comparing
women exposed during and after their reproductive years
with those exposed only as children. We also examine the
available life course data for non-pregnant women age 15
to 44 at some point in the 25-year period Jul-1990 through
Dec-2014, when the oldest was about 64 years old. For
comparison, we did a life course analysis for males.
Methods
Geographic descriptors
The term "County" describes the large, rural, sparsely
populated area of Mendocino County. "Willits" (exposed)
describes residents of ZIP-code 95490, which the County
uses to report public health statistics [42]. The com-
parison is to residents in the rest of the County (ROC)
(unexposed). From the 1970 census forward, these
demographically disadvantaged populations have been
among California’s more stable [21].
The 2010 census reported the following about these
communities: County, population 87841, area 3506
square miles (3+ times larger than the State of Rhode
Island); Willits ZIP-code 95490, population 13264, area
392 square miles; Willits proper (one of only four incor-
porated towns in the County), population 4888, area 2.8
square miles. The ZIP-code area enclosing Willits proper
includes dispersed housing located in redwood wilderness,
agricultural lands, and Native American rancherias.
Population data
California releases county-level population estimates by
age and sex annually, but sub-county population is avail-
able only every 10 years from the census. From the 1980,
1990, 2000, and 2010 censuses, we obtained county and
ZIP-code population by age and sex [43–47]. ZIP-code
was not available in 1980, so we used Tracts 106 and 107,
which correspond with Willits ZIP 95490.
Within age and sex, we calculated the percent of
Mendocino County population in Willits. We interpo-
lated these percentages to obtain estimated percents for
intercensal years, and extrapolated through 2014 using
the 2000–2010 rates of change. For each age, sex, and
year we multiplied the Willits percent times the county
population estimate yielding a Willits estimate. We sub-
tracted this from the county population to get ROC
population. Finally, we approximated birth year by sub-
tracting the age of the population estimated from the
year of the estimate. For example, the population age 44
in 2014 was born in 1970. Summing annual populations
within geography, sex and birth cohort yielded total
person-years, used as the denominator to calculate crude
birth rates and rates for life course models.
Patient discharge data
We used 1983–2014 confidential patient discharge data
(PDD) from California's Office of Statewide Health Plan-
ning and Development (OSHPD). These files were pre-
pared previously for longitudinal research with methods
described elsewhere [48]. Variables used include the pa-
tient’s birthdate, sex, ZIP-code, county of residence and
admission, admission date, disposition, and principal and
up to 24 secondary diagnoses (DX) and up to 20 secondary
procedures (PX) classified based on the International Clas-
sification of Diseases, 9th Revision. In July 1990, California
became the nation’s second state to include Social Security
Numbers (encrypted to protect confidentiality (SSNC)) in
discharge abstracts [49]. This key advance created the cap-
acity to link together a person’s hospitalization history from
1990 forward and study outcomes over the life course.
To classify conditions, we used Level 1 (Body System) and
Level 2 (Disease Condition) of the Multi-Level Clinical Clas-
sification Software (CCS) developed by the federal Agency
for Healthcare Research and Quality (AHRQ) [50]. The
CCS clusters diagnoses and procedures into a manageable
number of clinically meaningful categories. Level 1 groups
diagnoses (DXCH) and procedures (PXCH) by body system
and is ideal for evaluating large aggregations of conditions.
Level 2 groups diagnoses (DXCL) and procedures (PXCL)
within a body system. Following methods used by the
Healthcare Cost and Utilization Project [51], conditions
were identified by searching all available fields. We classi-
fied birth defects using CCS defined groups, and identified
others based on ICD-9 codes grouped by the Centers for
Disease Control. See Additional file 1 for descriptions of
groupers to select records and classify conditions.
From 1983 (first year data are available) through 2014
(last year available when we began this study), we ex-
tracted discharges with birth year 1950 forward, admitted
while living in the County. We classified records
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geographically as Willits (ZIP-code 95490) or ROC (any
other, with 11 missing ZIP-code). For life course models
(non-pregnant females and males), we added admissions
after people moved from the County. Data for life course
models are available only from July 1990 forward when
SSNC became available.
Crude birth rates
We defined the number of births in Willits and ROC as the
annual count of newborn discharges in the PDD. Popula-
tion denominators were the total populations of these areas
by year. We estimated crude birth rates (CBR) as the num-
ber of births per 1000 population. The CBR analysis used
JoinPoint to fit piecewise linear models and to test for sig-
nificant changes in slope between adjoining pieces [52, 53].
Reproductive outcome files
We examined reproductive outcomes using hospital dis-
charges of infants and pregnant women. Because newborn
infants rarely have SSNC and mothers had them only
since 1990, these were unlinked records of County resi-
dents from 1983–2014, identified at discharge as living in
Willits or ROC. The infant file included newborn dis-
charge records plus post-newborn records with age at ad-
mission less than one year. Post-newborn records are
essential in picking up transfers and conditions often not
noticed at birth. To check certain assumptions, a second-
ary analysis linked records for babies who were the only
birth in the County on a given day. The pregnant women
analysis file included any discharge record with a preg-
nancy diagnosis, age at discharge from 15 to 44 years, and
year of birth in the interval 1950 to 1989.
Models for infants and pregnant women examined the
rate of occurrence for various outcomes as a percent of
discharge records, within Willits and ROC, with relative
risk models comparing exposed (Willits) to unexposed
(ROC) rates. In relative risk models, the rate numerator
was the number of discharges with the outcome and the
denominator was the number of newborn or delivery
discharges, with rates rescaled per 10000.
For infants, we stratified by birth period as before (1983–
1996) or after (1997–2014) Plant closure. We ended the
pre-closure period in 1996 because the Plant closed in Dec-
1995 [12] and parents conceived most 1996 births in 1995.
For pregnant females, we stratified by 20-year generation
(born 1950–1969, 1970–1989), age at pregnancy (15–24,
25–34, 35–44), and whether the pregnancy was before or
after Plant closure. Results were so similar we focused on
generation. Thus, the reported models focus on when
people were born.
Life course files
In life course (cross-sequential) models [22] for non-
pregnant women and men, we define a person as the
combination of SSNC, sex, and birth year. We include
sex to identify a person because never-employed spouses
can use their partner's SSNC [49]. For patients age 18–64,
95% of County admissions had SSNC with no statistically
significant difference by sex or area, compared with 89%
for California. Thus, we had a high likelihood of identi-
fying adults no longer living in the County if admitted
at least once while living there. In making these files,
we excluded records lacking SSNC and SSNC with the
same sex and more than one birth year or too many
races or discharges, suggesting poor linkage.
We made life course files for non-pregnant females
(and males reported tangentially) to assess general
health, health of reproductive organs, and cancers. We
assigned 20-year generation using birth year: 1950–1969
“Mothers/Fathers”, and 1970–1989 “Daughters/Sons”.
These models used discharges from age 15 through
maximum age in 2014 (about 64), including discharges
after people moved out-of-county. We first searched the
recorded diagnoses and procedures on each record to
flag conditions of interest. Summarizing records within
person, a condition was set to 1 (true) if found on any
record. We summarized person-level data by generation,
divided summarized condition counts by external popu-
lation estimates, and rescaled the resulting rate per
10,000 person years.
One County hospital did not use SSNC as part of its
medical record system and we were unable to link re-
cords. Given this and other records without SSNC, we
reduced the denominator person-years by the percent of
in-county records with SSNC. This adjustment was
within strata defined by 10-year birth cohort, sex, and
Willits/ROC residence.
We assigned anyone who ever lived in Willits to Willits,
and anyone who ever lived in ROC to ROC, ignoring ad-
missions before the first in Willits for the Willits group
and admissions before the first in ROC for the ROC
group. To put the methodology in context, 52% of non-
pregnant women had 1 discharge, 19% had 2, and 29%
had 3 or more. Of 7057 women with more than one
record, 529 lived in both areas. About 17% of non-
pregnant women had post-County admissions, with no
between-group difference.
Statistical tests
When reporting results, we restrict use of the word
significant to reflect statistical significance, specifically
when the 2-tailed P-value is less than or equal to 0.05.
Without stratification, chi-square tests assessed the
statistical significance of relative risk (RR) with regard to
exposure, with RR greater than 1 indicating greater risk
in Willits. These models assessed data within a given
interval (e.g., pre- or post-closure, 20-year generation,
10-year age group) or overall.
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For stratified models, we used the Cochran-Mantel-
Haenzel (CMH) test of RR. The CMH test allows for
change of rate between strata, producing a combined
estimate of RR. We report RR with lower (LCL) and upper
(UCL) 95% confidence limits, obtained from the “Cohort
Study” row of the “Estimates of the Common Relative Risk
(Row1/Row2)” table produced by SAS Proc Freq. The
Breslow-Day Chi-Square (BD) test compares RR between
strata, that is, from one period to another, with the null
hypothesis that RR stayed the same. Except for JoinPoint
to analyse CBR trends, all programming was in SAS 9.4.
Results
Table 1 shows, by 20-year generation and 10-year cohort
within generation, potential exposure periods for people
who ever lived in Willits. The table also shows number
of records extracted for the four core models we de-
veloped: infant, pregnancy, non-pregnant female life
course, and male life course.
Table 1 addresses two important points. First, focusing
on the column set labelled “If Willits Resident Exposed
as”, each cohort within generation has slightly different
exposure possibilities. Second, focusing on Pregnancy
rows, only 199 admissions occurred post-closure among
women born between 1950 and 1959, while all but 43
admissions occurred post-closure among women born
between 1980 and 1989. This is the only birth interval
containing both infants and parents.
Fertility is a standard measure of population health,
specifically the CBR per 1000 population. Figure 1
compares CBR trends over the period 1983–2014 for
California, ROC, and Willits. The Plant began using
Cr(VI) 20 years earlier, before data were available.
California trends changed in 1990 and 1997, while
ROC trends changed in 1997 and 2008. By contrast,
Willits CBR declined steadily through 2000 before begin-
ning to increase. Inflection (or join) points have larger
round circles. For the 3-year start-of-period (1983–1985),
CBRs for both ROC and Willits were below the State,
Table 1 Number of records extracted by generation, exposure, model, and Plant period, 1983-2014
20-Year 10-Year If Willits Resident Model Discharges
Exposed as: Pre-closure Post-closure Row
Generation Cohort Ova Child Preg 1983-1996 1997-2014 Total
Mother/Father 1950-1959 No Yes Yes Infant
1950-1969 Pregnancy 5383 199 5582
Female life course 7279 14527 21806
Male life course 7221 14755 21976
1960-1969 Yes Yes Yes Infant
Pregnancy 9802 3152 12954
Female life course 4204 9843 14047
Male life course 4269 8090 12359
Daughter/Son 1970-1979 Yes Yes Some Infant
1970-1989 Pregnancy 4381 9853 14234
Female life course 1730 5798 7528
Male life course 1766 5100 6866
1980-1989 Yes Yes Few Infant 9101 9101
Pregnancy 43 10265 10308
Female life course 30 3569 3599
Male life course 64 4202 4266
Grand child 1990-1999 70% 70% No Infant 8781 3510 12291
1990-2009 2000-2009 No No No Infant 12224 12224
Great grand child 2010-2019 No No No Infant 5656 5656
2010-2029
Column Total Infant 17882 21390 39272
Pregnancy 19609 23469 43078
Female life course 13243 33737 46980
Male life course 13320 32147 45467
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with Willits lower than ROC. By the 3-year end-of-
period (2012–2014), the Willits CBR was not different
from the State.
We next turned attention to infant outcomes. Between
1983 and 2014, we found 33505 discharges of ROC
infants and 5767 of Willits infants age less than one
year. These include post-natal admissions (ROC = 4194,
Willits = 731) occurring after the newborn leaves the de-
livery hospital through age less than one year. ROC had
29311 newborn records and Willits had 5036.
Table 2 shows three groups of infant outcomes: condi-
tions originating in the perinatal period, other general
body system conditions, and congenital anomalies. The
first column identifies the group and condition. Columns
2 and 3 show by residence the rate per 100 discharges (%)
for the identified condition over the interval 1983–2014.
Ignoring time and compared with ROC infants, bolded
percentages indicate that Willits infants had signifi-
cantly higher rates for the following: short gestation
(preterm), low birth weight (LBW), or small for gesta-
tional age (SGA); macrosomia (large for gestational
age); perinatal jaundice; and conditions affecting the
nervous/sense system.
The next column set shows RR within period. Here, the
RR reflects the condition rate for Willits divided by the con-
dition rate for ROC. Within a period, a bolded number indi-
cates that Willits infants had a significantly different RR
than ROC infants. For example, in the pre-closure period
1983–1996, RR for Preterm/LBW/SGA was 1.11 for Willits
infants compared with ROC, and post-closure RR was 1.16.
The next column set shows RR adjusted for residence
and period. Newborn Willits infants consistently have
been less likely to be normal birth weight. For example,
risk for Willits’ newborn to be Preterm/LBW/SGA was
high over the period (1.14, 1.05–1.25). That is, they were
at about 14% increased risk (CMH P = 0.0029) with no
significant change after closure (BD P = 0.5801). They
also had overall 16% increased risk for macrosomia
(1.16, 1.04–1.29, CMH P = 0.0085), significantly higher
pre-closure (RR = 1.24), with no significant change post-
closure (RR = 1.12, BD P = 0.3939). Risk for intrauterine
hypoxia/asphyxia and perinatal jaundice dropped signifi-
cantly post-closure.
The next group reports general infant health conditions,
recorded by affected body system at birth or through the
first year of life. Physicians recorded the presence of one
or more conditions for about one-quarter of infant admis-
sions. Risk for infectious/parasitic and nervous conditions
was elevated over the interval and remained high relative
to ROC with no significant change post-closure. Similar
to newborn hypoxia/asphyxia, respiratory risk was high
pre-closure, lower post-closure, reflecting a significant
post-closure drop. Risk for digestive or genitourinary
conditions was not elevated during infancy.
Turning to congenital anomalies, risk for genitourinary
anomaly was non-significantly elevated pre-closure but
dropped significantly post-closure. Risk for a sub-group
of Other Congenital Anomalies – eye, ear, face, neck,
cleft, or chromosomal – was significantly high pre-closure,
with a significant drop post-closure.
Fig. 1 Births per 1000 population, California, ROC, Willits - 1983–2014
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Our next focus was on outcomes for pregnant women.
Between 1983 and 2014, we found 31444 discharges of
pregnant ROC women and 5558 of pregnant Willits
women age 15 to 44. These include admissions that did
not result in a live birth (ROC= 4395, Willits = 854). We
used total records as the denominator to show the percent
of pregnancy-related admissions by residence with the
identified condition over the interval 1983–2014. ROC
had 27049 delivery records and Willits had 4704, used as
the denominator to calculate relative risk statistics.
We focused on three groups of variables: general
health during pregnancy, conditions specific to preg-
nancy, and adverse pregnancy outcomes. Table 3 sum-
marizes health status of pregnant women admitted to
hospital by 20-year generation. As with infants, physi-
cians recorded the presence of one or more general
health conditions for about one-quarter of these admis-
sions, with more health problems for pregnant women
living in Willits (1.08, 1.03–1.13), and the younger gene-
ration (1970–1989) tending to be at greater general
health risk than the older generation (1950–1969).
As to conditions specific to pregnancy, birth, and the
puerperium, the finding of increased risk for Willits
women to have early labor is consistent with patterns in
infants for preterm birth. Other pregnancy indicators
tend to indicate normal or low risk for Willits.
A successful pregnancy results in one admission with
the birth of a live baby while admission that does not re-
sult in a live birth is high-risk. Table 4 stratifies admis-
sions not ending in live birth into two mutually
exclusive groups: those with return home still pregnant
(10.5%), and those without a live birth (pregnancy ter-
mination, 2.9%), with three main termination outcomes
listed separately: ectopic pregnancy, spontaneous abor-
tion, and pregnancy termination procedure.
Whether analysed by generation or pre/post closure, ad-
verse pregnancy outcomes were more common for Willits
women than ROC women with similar results no matter
how stratified. The earlier, pre-closure group of pregnant
Willits women had higher risk of returning home still preg-
nant than their ROC peers, with post-closure Willits
women at normal risk of returning home still pregnant.
Both generations of Willits women had significant in-
creased RR for pregnancy termination and sub-conditions.
Additionally, the 1960–1979 generation had high RR for
ectopic pregnancy and the 1950–1959 generation for ter-
mination procedures. We also stratified by age group, with
similar results.
Table 2 Infant conditions by residence, Plant period, and adjusted by period, 1983-2014
Condition Rate (%) Relative Risk per Birth Chi-sq P-Value
Discharges Within Period Adjust by Period
ROC Willits 83-96 97-14 RR LCL UCL CMH BD
Total discharges 33505 5767
Newborn 29311 5036
Post-natal admissions 4194 731
Origin in perinatal period
Preterm, LBW, SGA 8.30 9.43 1.11 1.16 1.14 1.05 1.25 0.0029 0.5801
Macrosomia 5.63 6.50 1.24 1.12 1.16 1.04 1.29 0.0058 0.3909
Intrauterine hypoxia/asphyxia 4.35 4.27 1.10 0.52 0.97 0.85 1.10 0.6139 0.0001
Respiratory distress syndrome 1.58 1.56 0.96 1.01 0.99 0.79 1.23 0.9203 0.8410
Perinatal jaundice 13.96 15.78 1.27 1.07 1.13 1.06 1.20 0.0002 0.0234
General infant health
General health condition (Any) 23.57 25.11 1.07 1.08 1.08 1.03 1.13 0.0013 0.5011
Infectious/parasitic 13.96 14.91 1.02 1.10 1.09 1.02 1.16 0.0070 0.4665
Endocr Nutri Metab Immun 2.01 1.96 0.94 1.00 0.98 0.80 1.19 0.8377 0.7761
Nervous/sense organs 5.19 5.98 1.11 1.19 1.17 1.05 1.31 0.0059 0.5950
Respiratory system 3.90 4.09 1.29 0.82 1.05 0.92 1.20 0.4942 0.0012
Digestive system 1.82 1.80 1.00 0.99 0.99 0.81 1.22 0.9587 0.9567
Genitourinary system 1.19 1.23 1.16 0.98 1.04 0.81 1.34 0.7500 0.5307
Congenital anomaly
Genitourinary 1.22 0.99 1.28 0.56 0.81 0.62 1.07 0.1428 0.0030
Eye ear face neck cleft chrom 0.93 1.11 1.59 0.93 1.19 0.91 1.56 0.1963 0.0489
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Our last focus was long-term life course outcomes. Spe-
cifically, for the 25-year period Jul-1990 to Dec-2014,
Table 5 shows results of the life course analysis summariz-
ing 30954 non-pregnant discharges for 11150 women ever
living in ROC, and 6700 for 2553 women ever living in
Willits. For comparison, Table 6 shows life course results
for males, summarizing 29556 discharges for 10997 men
ever living in ROC and 6094 for 2274 men ever living in
Willits.
Reflecting community burden of illness, physicians
admitted more Willits women and men per population and
they had more discharges per person. At an earlier life
stage, RR for younger Willits residents is equivalent to older
Willits residents. Conditions elevated for Willits residents
at birth or pregnancy are elevated over the life course.
With the oldest not yet age 65, Willits women and men
had increased risk for any neoplasm and genitourinary
conditions. Willits women had higher risk for reproduc-
tive and benign neoplasms and for reproduction-related
conditions: pelvic inflammatory disease, endometriosis,
menstrual disorders, ovarian cysts, and reproductive organ
surgeries.
Discussion
Cr(VI) causes DNA strand breaks, chromium-DNA ad-
ducts, DNA protein cross links, and oxidative DNA dam-
age [54–58], damaging mammalian cells by binding to
and distorting DNA, causing aberrant expression. Helped
by nonspecific anion carriers, Cr(VI) crosses the cellular
membrane, links with oxygen, and is a strong oxidizing
Table 3 Pregnancy conditions by residence, generation, and adjusted by generation, 1983-2014
Condition Rate (%) Relative Risk per Delivery Chi-sq P-Value
Discharges Within Generation Adj by Generation
ROC Willits 1950 1970 Ratio LCL UCL CMH BD
Pregnancy admissions 31444 5558
Deliveries 27049 4704
Non-delivery admissions 4395 854
General health in pregnancy
Body system condition (Any) 24.62 26.11 0.96 1.12 1.08 1.03 1.13 0.0007 0.0026
Infectious/parasitic 9.94 10.94 1.24 1.11 1.13 1.04 1.22 0.0033 0.5211
Endocr Nutri Metab Immun 3.65 4.12 1.02 1.19 1.15 1.00 1.32 0.0434 0.3686
Blood/blood-forming organs 5.07 4.35 0.90 0.87 0.88 0.77 1.00 0.0476 0.8029
Mental disorders 4.64 6.42 1.06 1.53 1.41 1.26 1.58 0.0000 0.0082
Nervous system sense 1.20 1.53 0.54 1.64 1.30 1.03 1.64 0.0281 0.0007
Circulatory system 1.57 1.71 0.82 1.19 1.11 0.89 1.38 0.3499 0.2037
Respiratory system 2.11 2.68 1.05 1.39 1.30 1.09 1.54 0.0037 0.1854
Digestive system 2.32 2.30 0.73 1.15 1.01 0.84 1.22 0.9037 0.0353
Genitourinary system 3.32 3.65 1.00 1.18 1.12 0.97 1.30 0.1282 0.3181
Pregnancy, birth, puerperium
Hemorrhage in pregnancy 2.28 1.93 0.84 0.88 0.86 0.70 1.05 0.1342 0.8023
Hypertension in pregnancy 5.92 6.23 1.06 1.08 1.07 0.96 1.20 0.2248 0.8541
Early labor 9.97 10.67 1.09 1.09 1.09 1.00 1.18 0.0451 0.9549
Long pregnancy 7.25 6.71 1.06 0.92 0.95 0.85 1.05 0.2907 0.2508
Diabetes mellitus in pregnancy 5.64 4.28 0.94 0.71 0.77 0.68 0.88 0.0001 0.0383
Malposition 6.04 6.12 1.07 1.00 1.03 0.92 1.15 0.5937 0.5094
Pelvic obstruction 5.21 4.84 0.87 1.02 0.94 0.83 1.07 0.3675 0.2110
Previous Cesarean-section 10.37 10.04 1.01 0.96 0.98 0.91 1.07 0.7226 0.5905
Fetal distress 17.89 17.27 1.03 0.94 0.98 0.92 1.04 0.5634 0.1395
Premature rupture amniotic fluid 4.56 4.28 0.95 0.96 0.95 0.84 1.09 0.4954 0.8935
Hydramnios 2.04 1.53 0.55 0.87 0.76 0.61 0.95 0.0170 0.0827
Umbilical cord 17.87 18.01 1.12 0.98 1.03 0.97 1.09 0.3750 0.0311
Other: Reproductive anomaly 2.26 2.28 0.98 1.06 1.03 0.86 1.24 0.7518 0.6947
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agent. Intracellular reduction of Cr(VI) to Cr(III) leads to
extensive formation of DNA-phosphate-based adducts,
causing genetic damage [59]. As a result, Cr(VI) is toxic,
carcinogenic, mutagenic, and teratogenic.
In this context, we organize our findings in two major
sections: the impact of non-occupational Cr(VI) exposure
on reproductive health and general health. We close with
a discussion of the study’s strengths and weaknesses.
This study focused primarily on reproductive prob-
lems. Both animal and human occupational studies con-
firm that exposing a pregnant female to a teratogenic
chemical will harm the pregnancy. Animal studies also
indicate that exposing a female before reproductive age
is as harmful as exposure in pregnancy. A primary pur-
pose of this study was to determine if similar harm oc-
curs in domestically exposed women. We focused on
pregnancy outcomes and the health of two generations
of mothers and babies.
A critical concept underlies our work: generational
change. As Table 1 showed, except for people arriving
after Plant closure, the entire population of Willits
was exposed to Cr(VI) before closure. Of the older
generation (1950–1969, 78% of pre-closure pregnancy
admissions), most were exposed during reproductive
years. Given later exposure, reproductive organs of
many in the 1950 generation would have developed
more normally but their ova would be vulnerable.
Among the younger generation (1970–1989, 85% of post-
closure pregnancy admissions), most were exposed from
conception forward but were mainly unexposed during
reproduction. Females exposed while ovaries are de-
veloping have damage to their reproductive system,
which includes inhibition of the ability to conceive
and when they do conceive, adverse pregnancy out-
comes [60].
As compared with ROC, both generations of Willits
women had significantly increased risk of pregnancy
terminations and of bearing infants with abnormal
weight or term, with no significant between-generation
differences. Thus, as with animal studies, adverse out-
comes were similar in both populations. The growing
number of grandchildren will make possible the study
of a third generation’s reproduction.
For now, the immediate question was how did babies
fare? Since spontaneous abortion is the only condition
studied in both animals and humans, we examined if the
overall birth rate in Willits differed. In 1983, when the
Plant had been using Cr(VI) for two decades, the Willits
CBR was significantly lower than ROC. Compared with
ROC and the State, the Willits CBR remained low
Table 4 Non-delivery pregnancy events per 10,000 deliveries by time measure, period and residence, 1983-2014
Outcome Time Residence Adj Rel Risk Chi-sq P-Value
Measure Period ROC Willits RR Ratio LCL UCL CMH BD
Return home still Generation 1950-1969 1273 1461 1.15
Pregnant 1970-1989 1075 1027 0.96 1.05 0.97 1.14 0.2614 0.0310
Plant 1983-1996 1350 1541 1.14
1997-2014 1005 930 0.93 1.04 0.96 1.13 0.3173 0.0144
Pregnancy termination Generation 1950-1969 433 539 1.25
1970-1989 223 303 1.36 1.29 1.11 1.50 0.0011 0.6197
Plant 1983-1996 400 488 1.22
1997-2014 245 336 1.37 1.28 1.10 1.50 0.0014 0.4798
Ectopic pregnancy Generation 1950-1969 209 200 0.96
1970-1989 77 126 1.63 1.17 0.92 1.50 0.2081 0.0369
Plant 1983-1996 199 193 0.97
1997-2014 82 129 1.57 1.16 0.91 1.48 0.2420 0.0566
Spontaneous abortion Generation 1950-1969 51 91 1.78
1970-1989 25 46 1.83 1.80 1.20 2.68 0.0038 0.9490
Plant 1983-1996 45 85 1.88
1997-2014 29 49 1.66 1.79 1.19 2.67 0.0042 0.7703
Therapeutic D&C Generation 1950-1969 141 234 1.66
1970-1989 90 111 1.23 1.47 1.15 1.88 0.0020 0.2449
Plant 1983-1996 135 233 1.72
1997-2014 93 105 1.13 1.46 1.14 1.87 0.0024 0.1080
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Table 5 Non-pregnant female health by place, generation, and adjusted by generation, life-course 1990-2014
Condition Rate (%) Relative Risk per Population Chi-sq P-Value
People Within Generation Adj by Generation
ROC Willits 1950 1970 Ratio LCL UCL CMH BD
Illness burden
People 11150 2553 1.16 1.25 1.19 1.14 1.24 0.0000 0.1234
Discharges 30954 6700 1.10 1.19 1.12 1.10 1.15 0.0000 0.0095
General health
Infectious/parasitic 24.33 24.44 1.23 1.10 1.19 1.09 1.30 0.0001 0.2663
Endocr Nutri Metab Immun 46.94 47.36 1.19 1.23 1.20 1.13 1.28 0.0000 0.6632
Mental disorders 52.83 56.48 1.26 1.28 1.27 1.20 1.34 0.0000 0.8635
Nervous system sense organs 28.88 32.67 1.33 1.37 1.34 1.25 1.45 0.0000 0.7437
Circulatory system 34.39 36.51 1.24 1.37 1.26 1.18 1.36 0.0000 0.2785
Respiratory system 30.45 34.04 1.31 1.37 1.33 1.23 1.43 0.0000 0.5789
Digestive system 45.70 50.76 1.31 1.35 1.32 1.24 1.40 0.0000 0.6283
Reproductive health
Neoplasm 24.76 24.83 1.16 1.42 1.20 1.10 1.30 0.0000 0.0933
Reproductive organ 6.28 6.70 1.27 1.27 1.27 1.08 1.50 0.0046 0.9961
Benign 15.87 15.08 1.11 1.32 1.13 1.02 1.27 0.0254 0.2725
Genitourinary system 46.30 47.12 1.17 1.34 1.21 1.14 1.29 0.0000 0.0571
Pelvic inflammatory disease 13.61 15.04 1.28 1.42 1.31 1.17 1.47 0.0000 0.4313
Endometriosis 11.28 11.32 1.18 1.26 1.19 1.05 1.36 0.0064 0.6768
Menstrual disorder 14.91 14.45 1.07 1.44 1.15 1.03 1.29 0.0129 0.0252
Ovarian cyst 7.46 8.97 1.38 1.53 1.43 1.23 1.65 0.0000 0.5278
Reproductive organs (PX) 6.57 5.37 1.09 1.41 1.15 1.06 1.25 0.0006 0.0086
Table 6 Male health by place, generation, and adjusted by generation, life-course 1990-2014
Condition Rate (%) Relative Risk per Population Chi-sq P-Value
People Within Generation Adj by Generation
ROC Willits 1950 1970 Ratio LCL UCL CMH BD
Illness burden
People (N) 10997 2274 1.16 1.20 1.17 1.12 1.23 0.0000 0.4643
Discharges (N) 29556 6094 1.15 1.20 1.16 1.13 1.20 0.0000 0.2952
General health
Infectious/parasitic 26.60 28.50 1.22 1.37 1.25 1.15 1.37 0.0000 0.2481
Endocr Nutri Metab Immun 41.47 43.00 1.21 1.22 1.21 1.13 1.30 0.0000 0.9556
Mental disorders 58.04 58.57 1.18 1.20 1.18 1.11 1.26 0.0000 0.7732
Nervous system sense organs 27.87 32.38 1.32 1.50 1.36 1.25 1.48 0.0000 0.1803
Circulatory system 39.28 41.15 1.19 1.41 1.23 1.14 1.32 0.0000 0.0912
Respiratory system 31.39 33.81 1.23 1.35 1.26 1.16 1.37 0.0000 0.3461
Digestive system 41.25 44.67 1.24 1.36 1.27 1.18 1.36 0.0000 0.2280
Reproductive health
Neoplasm 9.93 10.25 1.16 1.50 1.21 1.04 1.40 0.0107 0.2163
Genitourinary system 19.84 21.66 1.22 1.51 1.28 1.16 1.41 0.0000 0.0933
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through 2000, and did not rise to the State average until
12 years after Plant closure.
For the infant analysis, we focused on pre- and post-
closure. From Table 1, most pre-closure births are births
of the younger generation (1970–1989), exposed from
conception forward, now having children post-closure.
Health of post-closure babies, theoretically always unex-
posed, reflects the impact on reproductive capacity of
early maternal exposure to Cr(VI).
In both infant and maternal models, regardless of time
measure, and consistent with the established effect of
Cr(VI), risk for abnormal birth weight or term was
higher for Willits than ROC. Abnormal birth weight is
often caused by endocrine/metabolic disorders in the
mother [61–63]. During pregnancy and over the avail-
able life course, Willits women had elevated risk for
endocrine conditions including thyroid disorders, dia-
betes, hyperlipidemia, and other endocrine conditions.
Cr(VI) is a well-known endocrine disrupter [35].
Infants born before closure, primarily the 1970 gener-
ation of children born to the 1950 generation of mothers,
were exposed to Cr(VI) in utero. Compared to ROC, that
generation had significantly higher risk for a group of eye,
ear, face, neck, cleft, and chromosomal anomalies and
elevated risk for genitourinary anomalies. These are well-
established effects of Cr(VI) exposure [23–25]. Post-
closure, risk for both anomaly types dropped significantly.
We took particular interest in pregnancy admissions
that resulted in termination without a live birth. Regard-
less of generation, pregnant women in Willits had sig-
nificant risk of pregnancy loss, which we see in-hospital
through ectopic pregnancies, spontaneous abortions,
and therapeutic abortion procedures.
Ectopic pregnancies were the most frequent cause of
in-hospital pregnancy loss in the younger generation of
women, exposed during childhood. In the general popu-
lation, these usually reflect defective embryo implant-
ation due to scarred fallopian tubes caused by infectious
pelvic inflammatory disease [64]. Cr(VI) is adept at pro-
ducing non-infectious inflammation [65]. As reported
earlier [21] and found here, Willits residents had in-
creased risk of in-hospital screening for infections. This
suggests that physicians, unaware of the effects of
Cr(VI), struggle to find a septic etiology for conditions
associated with inflammation.
Until closure, most Willits females were continuously
exposed to Cr(VI). Subtle abnormalities may not become
apparent until reproductive age, manifesting as sterility or
miscarriage, bearing infants of abnormal weight or term,
or having reproductive organ abnormalities. Compared to
ROC, over the available life course, both generations of
Willits females had increased risk for endometriosis, men-
strual irregularities, ovarian cysts, and surgical procedures
such as hysterectomies and oophorectomies. We also
found higher cancer risk in both generations of Willits
males and females, and among females, reproductive and
benign neoplasms, predicting increased future risk in
these and other cancers in the Willits population.
Unlike men whose spermatozoa can be damaged at
any time from puberty onward, the female oocyte is par-
ticularly vulnerable to toxic exposure mutations at two
periods: the first 13 weeks of gestation, and later as an
adult at each ovulation. In the first weeks of female ges-
tation, developing oocytes and supporting cells such as
somatic granulosa and the extracellular matrix undergo
maturational events. These primordial follicles lie dor-
mant until puberty, when the ovary releases one or more
monthly to begin follicle development. The oocyte once
more becomes vulnerable to mutational change. These
events during fetal development determine adult fertility
and reproductive capacity.
Studies of pregnancies of exposed women cannot ignore
the contribution of exposed mates. One of several articles
reporting male mediated spontaneous abortion examined
couples with metal worker husbands, planning their first
pregnancy [36]. Loss increased linearly with the number of
years men were exposed to Cr(VI). Animal studies confirm
poor sperm quality of exposed males and fetal resorption
when mated with unexposed females. This suggests peri-
implantation mortality of fertilized ova, which certainly can
contribute to low birth rate and spontaneous abortions,
since many women would have married men who worked
at the Plant, the largest employer in Willits. However, as
others have reported in animal studies, reproductive prob-
lems in women exposed to Cr(VI) go beyond miscarriage.
In terms of general health, respiratory conditions are
among the most firmly established adverse events for
Cr(VI) exposure. In the newborn infant, in utero hypoxia/
asphyxia is due to relative hypoxia of the mother. Res-
piratory distress in infants likely was caused by ambient
Cr(VI). Before Plant closure, risk of these conditions
were not different from ROC. Both dropped signifi-
cantly post-closure in Willits infants.
When pregnant, women living in Willits had ele-
vated risk of respiratory problems. When not preg-
nant, they had increased risk overall and for all sub-
conditions with no generation difference. Local physi-
cians had blamed high asthma rates on traditional air
quality factors such as smog, smoke, wildfires, or
burning trash. We earlier showed that these factors
were not different between ROC and Willits [21]. The
County was equal to or better than the State, and air qual-
ity as usually understood could not cause high illness rates
in Willits. A recent California study found that the County
has the third lowest lifetime asthma incidence in the State
[66]. With similar results for males, our findings are con-
sistent with established pulmonary scarring associated
with Cr(VI) [67, 68].
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Digestive system disorders and particularly liver disor-
ders are other established sequelae of Cr(VI) exposure.
Compared to ROC, Willits infants born of the 1950 gener-
ation had increased perinatal jaundice. This dropped signifi-
cantly but remained elevated in infants of the 1970 Willits
generation who became pregnant after Plant closure. The
older generation of pregnant Willits women had a signifi-
cantly lower risk of digestive system disorders than the
younger generation, but over the life course, both genera-
tions had elevated risk of all digestive sub-system disorders.
Cr(VI) is a well-established hepatotoxin, producing apop-
tosis and oxidative stress in human liver cells, and inter-
acting with the liver at all maturation phases [69].
Unlike other general health conditions, risk for Willits
infants to have nervous system conditions was signifi-
cantly high and did not drop post-closure. Whether
pregnant or not, both generations of Willits females and
males had more nervous system and mental health condi-
tions. When not pregnant, nervous system sub-conditions
at greater risk included epilepsy, migraines, and congenital
nervous system conditions, all understood to have under-
lying genetic components.
Cr(VI) readily crosses the blood brain barrier and de-
posits in the human brain [70], causing brain alterations,
with marked degeneration of the cerebral cortex [71].
Cr(VI) conclusively causes behavioural deficits that are
relevant for humans [72]. Costa and Klein identified central
nervous system toxicity of Cr(VI) in workers [54]. Their
findings mirror ours in domestically exposed humans.
Finally, we turn attention to the study strength and
weaknesses. Other health officers and researchers con-
cluded that exposure to Cr(VI) was high when the Plant
was open and that exposure estimates likely were low.
The range of symptoms elevated among Willits women
and their infants is consistent with the complex impact
of Cr(VI). Since beginning this work in 2007, we have
used four different census-based population estimates
and several different designs, all with consistent results.
Disease classification was reasonably accurate. Coding
rules specify that physicians only identify secondary diagno-
ses considered relevant to treating the patient’s principal ill-
ness. Physicians identify these conditions over the course of
care, with listing finalized at discharge. Hospital records are
less subject to recall bias because they are the basis for de-
veloping treatment plans and billing for care. AHRQ devel-
oped the CCS to classify standard health conditions and
procedures to facilitate surveillance and outcome research.
From the 1970 through 2000 census, these areas were
in California’s top ranges for measures of population sta-
bility, and were demographically similar [21]. The 2010
census reports a large population drop for Willits proper
but no drop in the enclosing ZIP 95490. This suggests
people moved from Willits proper to the larger area.
Census questions asking where people lived 5 years earlier
show that residents tended to move locally and our linked
life course models reflect this.
In these models, people may move but we know where
they lived when admitted to hospital. About 4% moved
within County, and proportionately more Willits residents
moved to somewhere in ROC after ATSDR confirmed Plant
exposures. This is why we slightly modified the life course
design for this paper. However, this modification returned no
important change in risk differences between Willits and
ROC.
Our design assumes that residence at discharge was ap-
plicable to earlier points in time. In the case of pregnancy,
we do not know if the mother was born in the area she
gave as residence or how long she lived there before or
during pregnancy. In the case of fetal exposure, most con-
ceptions probably occurred in the area the mother identi-
fied as her residence at delivery. Other research suggests
that incorrect geographic assignment of mothers or in-
fants would create a bias toward the null hypothesis, but
would not reduce the differences found [73, 74].
As described earlier [21], available data does not per-
mit us to identify Plant employees or family members.
People who worked in Willits (at the Plant or otherwise)
and lived elsewhere will be classified incorrectly. County
residents never hospitalized while living there are not in-
cluded. Although data suggest population stability, we
do not know how long patients lived in the County,
when they arrived, or when (or if ) they left. We have no
way to assess these limitations or overcome them.
Remy separately addressed other possible methodologic
issues [75]. She showed that: time measures used are valid
both conceptually and quantitatively; hospital coding
variability does not distort results; number of admissions be-
fore living in the County do not differ; demographic or so-
cioeconomic differences between Willits and ROC are not
significant, and both tend to be different from the State.
Given Remy’s report, life course methods used here better
address missing SSNC and movement between geographic
areas.
Despite a number of small design modifications in
various reports over now ten years, none importantly
changed our understanding of health outcomes in Will-
its. In the context of uncertainty about geography,
period, duration, and extent of exposure, we have come
to believe that the risk reported based on ZIP-code is
conservative, and that the true risk is more toward the
upper tail of the confidence intervals.
We once more urge a well-designed study to collect
data about individuals who lived in Willits during child-
hood and the reproductive period.
Conclusions
For the first time, available data suggests the detrimental ef-
fects of domestic Cr(VI) exposure on human reproductive
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health. We focused primarily on reproductive health of ex-
posed females and their babies. Our findings closely mirror
those of many investigators reporting on all phases of ani-
mal Cr(VI) studies.
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